San Diego, CA, United States of America

Sanjeev Sharma

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Onyx Therapeutics, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjeev Sharma. Retrieved from https://idiyas.com/inventor/sanjeev-sharma-5g4nexyc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sanjeev Sharma: Innovator in Pharmaceutical Formulations

Introduction

Sanjeev Sharma is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release formulations.

Latest Patents

Sanjeev Sharma holds a patent for "Modified release formulations for oprozomib." This patent features modified release pharmaceutical formulations, including extended release solid dosage forms such as tablets. These formulations are designed for the oral administration of oprozomib or its pharmaceutically acceptable salts to human or animal subjects.

Career Highlights

Sanjeev is currently associated with Onyx Therapeutics, Inc., where he applies his expertise in pharmaceutical innovations. His work focuses on enhancing the efficacy and delivery of medications through advanced formulation techniques.

Collaborations

Throughout his career, Sanjeev has collaborated with talented professionals, including Mouhannad Jumaa and Tony Muchamuel. These collaborations have contributed to the advancement of pharmaceutical research and development.

Conclusion

Sanjeev Sharma's innovative work in modified release formulations exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions continue to shape the future of medication delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…